Published in:
Open Access 01-12-2019 | Gout | Letter
Point-of-care uric acid testing is useful in routine clinical care of gout
Published in: Arthritis Research & Therapy | Issue 1/2019
Login to get accessExcerpt
Fabre et al. recently reported that the HumaSensplus point-of-care uric acid (UA) meter performed well in comparison to venous UA in a cohort of 238 diabetic patient [1]. We have performed a service evaluation of the HumaSens2.0plus UA meter in patients seen in a specialist gout clinic for investigation or review. All patients attending the clinic from August 2017 onward were offered fingerprick testing with results compared to a venous sample analysed using an Abbott colorimetric uricase assay as part of standard care. Summary characteristics of the patients included in the study are given in Table 1 with complete data available in Additional file 1.
Table 1
Characteristics of study population (n = 131)
|
Characteristic
|
Value
|
|---|---|
|
Gout
|
124 (94.6%)
|
|
Visible tophi
|
41 (31.3%)
|
|
Age (years)
|
58.1 (± 16.2)
|
|
Male sex
|
110 (84.0%)
|
|
Weight (kg)
|
91.9 (± 21.7)
|
|
Alcohol (u/week)
|
9.7 (± 13.2)
|
|
Diuretics
|
25 (19.1%)
|
|
Anti-hypertensive medication
|
44 (33.6%)
|
|
Urate lowering therapy
|
98 (74.8%)
|
|
Renal impairment
|
eGFR < 30 ml/min/1.73m2 2 (9.1%)
eGFR 30–60 ml/min/1.73m2 23 (17.5%)
|